Observed arrival · 2026-10-05

A benchmark that asks agents when not to call a biomarker

onc-agi.com Visit website

Editorial interest 78/100 Selection signal · not a rating of the site

ONC-AGI presents an interactive benchmark in which an agent must identify which measurements drive a cancer-cohort outcome—or return an empty list.

Landing page captured for the 2026-10-05 issue.

For: Researchers and builders evaluating scientific-discovery agents
Worth noticing: Each assay costs $108 per patient; the page lists a 240-patient reference study at $17,280.

Field notes

The demo offers patient batches from 30 to 240 at a stated $108 per patient, and lists a 240-patient reference study at $17,280. Evidence appears as −log10 p-value bars grouped by measurement type; hollow bars mark measurements taken after the outcome, and a multiple-testing line is shown. The page says a non-JavaScript view displays evidence after 90 patients.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible

✦PrettyNotable craft visible

●ProPolished or operationally mature

◎NicheUnusually specific use

One card from the complete issue

Still the Old Commit

307,787 arrived 1,000 judged 978 catalogued Enter the complete issue